CytomX Therapeutics to Present at Upcoming March Investor Conferences

On February 27, 2024 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, reported that management will participate in the following investor conferences in March (Press release, CytomX Therapeutics, FEB 27, 2024, View Source [SID1234640512]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen’s 44th Annual Health Care Conference
Date: Tuesday, March 5, 2024
Formal Presentation: 2:50 p.m. ET
Location: Boston, MA

Barclays 26th Annual Global Healthcare Conference
Date: Thursday, March 14, 2024
Fireside Chat: 11:45 p.m. ET
Location: Miami, FL

Live webcasts of the TD Cowen presentation and Barclays fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.